Mi Y - Search Results

1

Hollow multishelled heterostructures with enhanced performance for laser desorption/ionization mass spectrometry based metabolic diagnosis.

Pei C, Su R, Lu S, Chen X, Ding Y, Li R, Shu W, Zeng Y, Lin Y, Xu L, Mi Y, Wan J. Pei C, et al. Among authors: mi y. J Mater Chem B. 2023 Aug 30;11(34):8206-8215. doi: 10.1039/d3tb00766a. J Mater Chem B. 2023. PMID: 37554072

2

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

Mi YQ, Shi QY, Xu L, Shi RF, Liu YG, Li P, Shen F, Lu W, Fan JG. Mi YQ, et al. Dig Dis Sci. 2015 Jan;60(1):243-51. doi: 10.1007/s10620-014-3341-x. Epub 2014 Sep 7. Dig Dis Sci. 2015. PMID: 25194851

3

[Impact of liver steatosis on the curative effect of pegylated interferon-alpha-2a in patients with chronic hepatitis B].

Xu L, Li P, Shi Q, Mi Y. Xu L, et al. Among authors: mi y. Zhonghua Gan Zang Bing Za Zhi. 2015 Feb;23(2):99-102. doi: 10.3760/cma.j.issn.1007-3418.2015.02.005. Zhonghua Gan Zang Bing Za Zhi. 2015. PMID: 25880974 Chinese.

4

[Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan].

Xu L, Li P, Lu W, Shi Q, Shi R, Zhang X, Liu Y, Wang Q, Fan J, Mi Y. Xu L, et al. Among authors: mi y. Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):108-13. doi: 10.3760/cma.j.issn.1007-3418.2016.02.007. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 26983477 Chinese.

5

[The significance of 8-hydroxy-deoxyguanosine acid in the diagnosis of nonalcoholic steatohepatitis].

Jiang Y, Han T, Zhang ZG, Lu SQ, Mi YQ, Xu L, Qi FX, Zhang Y, Song GD. Jiang Y, et al. Among authors: mi yq. Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):34-38. doi: 10.3760/cma.j.issn.0578-1426.2017.01.009. Zhonghua Nei Ke Za Zhi. 2017. PMID: 28056321 Chinese.

6

A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.

Xu L, Lu W, Li P, Shen F, Mi YQ, Fan JG. Xu L, et al. Dig Liver Dis. 2017 Aug;49(8):910-917. doi: 10.1016/j.dld.2017.03.013. Epub 2017 Mar 30. Dig Liver Dis. 2017. PMID: 28433586

7

[Characteristics, diagnostic and therapeutic strategies for chronic hepatitis B combined with non-alcoholic fatty liver disease].

Xu L, Mi YQ. Xu L, et al. Among authors: mi yq. Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):198-202. doi: 10.3760/cma.j.cn501113-20200107-00008. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32306651 Chinese.

8

Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients.

Jiang B, Su R, Ren D, Zheng X, Cao Y, Mi Y, Wang F, Ma P. Jiang B, et al. Among authors: mi y. Virus Res. 2020 Dec;290:198117. doi: 10.1016/j.virusres.2020.198117. Epub 2020 Aug 13. Virus Res. 2020. PMID: 32800804

9

Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.

Tao X, Zhao Y, Chen L, Zeng M, Mi Y, Xu L. Tao X, et al. Among authors: mi y. Hepatology. 2022 Jul;76(1):E13-E14. doi: 10.1002/hep.32389. Epub 2022 Mar 6. Hepatology. 2022. PMID: 35112375 No abstract available.

10

Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination.

Chen L, Tao X, Zhao Y, Zeng M, Mi Y, Xu L. Chen L, et al. Among authors: mi y. Aliment Pharmacol Ther. 2022 Apr;55(8):1059-1060. doi: 10.1111/apt.16834. Aliment Pharmacol Ther. 2022. PMID: 35362130 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,843 results

Search Page

Filters